F D C Ltd
Ticker: FDC
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
460.65
Market Cap
7499.85
Debt/Equity
0.0093
ROE %
12.188
PB
3.2878
Promoter %
69.658
Pledge %
0.000
1Y Rev Growth %
7.542
5Y Rev Growth %
9.245
NP Margin %
12.134
NP Margin 5Y Avg %
14.441
Trading Reference
1M Return %
2.229
6M Return %
8.926
1Y Return %
-15.717
% Away 52W High
20.699
% Away 52W Low
25.775
Daily Volume
252550
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 31/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
F D C Ltd shows stable growth potential in the pharmaceutical sector.
✅ Positives
- Strong product portfolio in pharmaceuticals
- Consistent revenue growth over recent quarters
- Robust R&D capabilities for innovation
⚠️ Negatives
- Regulatory challenges in the industry
- High competition affecting market share
- Dependence on a few key products
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
S
Sandur Manganese and Iron Ores Ltd
The company shows potential with stable growth but faces challenges in profitability and market conditions.
View details
M
Mishra Dhatu Nigam Ltd
Mishra Dhatu Nigam Ltd shows potential due to its positioning in a growing sector, but inconsistent growth and valuation concerns warrant caution.
View details
P
Prism Johnson Ltd
Prism Johnson Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability.
View details
L
Lumax AutoTechnologies Ltd
Lumax AutoTechnologies Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised for investors.
View details
A
AJAX Engineering Ltd
AJAX Engineering Ltd shows potential for growth but faces challenges in profitability and market competition.
View details
G
Gujarat Narmada Valley Fertilizers & Chemicals Ltd
The company operates in a crucial sector but faces several challenges that may impact future growth and profitability.
View details
Y
Yatharth Hospital & Trauma Care Services Ltd
Yatharth Hospital shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
R
Rategain Travel Technologies Ltd
Rategain Travel Technologies Ltd shows potential in a recovering travel sector, but faces challenges in growth consistency and valuation metrics.
View details
A
Arvind Fashions Ltd
Arvind Fashions Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment, despite some strengths in the business model.
View details
V
Voltamp Transformers Ltd
Voltamp Transformers Ltd shows potential for growth in a vital sector, but faces challenges in profitability and valuation metrics.
View details
F
Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
Q
Quality Power Electrical Equipments Ltd
Quality Power Electrical Equipments Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
J
Just Dial Ltd
Just Dial Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
G
Ganesh Housing Ltd
Ganesh Housing Ltd presents a risky investment with several challenges in growth and profitability metrics.
View details
I
Isgec Heavy Engineering Ltd
Isgec Heavy Engineering Ltd shows potential for growth in a future-ready sector, but faces challenges in valuation and execution risks.
View details
P
Praj Industries Ltd
Praj Industries Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
Business Overview
F D C Ltd is a leading Indian pharmaceutical company dedicated to enhancing healthcare through innovative products and solutions. Catering to a diverse audience, including healthcare professionals and patients, F D C Ltd focuses on quality and accessibility in medicine. The company’s commitment to research and development ensures a robust pipeline of essential drugs, making it a trusted partner in the healthcare ecosystem. With a strong distribution network and a reputation for excellence, F D C Ltd plays a vital role in improving health outcomes across India.
- Established leader in the Indian pharmaceutical sector
- Wide range of quality healthcare products
- Strong focus on research and innovation
- Trusted by healthcare professionals and patients
- Extensive distribution network across India
Investment Thesis
F D C Ltd stands out with a strong promoter group that enhances its credibility in the market. The company's focus on expanding digital services presents a significant growth opportunity. Coupled with its attractive valuation compared to peers, F D C Ltd offers a compelling investment proposition for retail investors seeking long-term gains.
- Strong promoter group ensures credibility and trust.
- Significant growth potential in digital services sector.
- Attractive valuation compared to industry peers.
- Consistent financial performance with robust fundamentals.
- Strategic initiatives aimed at expanding market presence.
Opportunity vs Risk
Opportunities
- Growing e-commerce sector
- Expansion into new markets
- Strong brand loyalty
- Innovative product offerings
- Rising disposable incomes
Risks ⚠️
- Intense competition in retail
- Supply chain disruptions
- Economic downturns
- Regulatory changes
- Changing consumer preferences
Peer Perspective
F D C Ltd trades at a slight premium to peers like Cipla and Sun Pharma, reflecting its stable margins. A sustained growth acceleration could trigger a rerating, enhancing its appeal among investors.
Future Outlook
F D C Ltd is well-positioned for growth, driven by strong market demand and innovative product offerings; however, maintaining effective execution and cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does F D C Ltd do?A: F D C Ltd is involved in manufacturing and marketing pharmaceutical and healthcare products.
- Q: Is F D C Ltd a good investment?A: Investment suitability depends on individual financial goals and market conditions. Research is recommended.
- Q: What are the risks of investing in F D C Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of F D C Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the dividend policy of F D C Ltd?A: F D C Ltd has a history of paying dividends, but future payments depend on company performance.
📊 Stock Investment Checklist (100 Points)
F D C Ltd • Updated: 2025-09-16 20:48:00
-
10BusinessHighThe company operates in the pharmaceutical sector, which is generally considered future-ready due to ongoing demand for healthcare.
-
10GrowthHighConsistent revenue growth over the past few years, but profit growth has been somewhat volatile.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow from operations has shown some inconsistency.
-
8ValuationHighValuation ratios are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios suggest some caution.
-
6GovernanceGoodPromoter holding is reasonable, but there are some concerns regarding pledging.
-
5DriversGoodGrowth drivers are present, but execution risks remain significant.
-
5TechnicalsGoodMarket sentiment is neutral with moderate liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
F D C Ltd shows potential for growth in a stable sector, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100